Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS
1993; Massachusetts Medical Society; Volume: 329; Issue: 12 Linguagem: Inglês
10.1056/nejm199309163291202
ISSN1533-4406
AutoresStephen D. Nightingale, D. William Cameron, Fred M. Gordin, Paul M. Sullam, David L. Cohn, Richard E. Chaisson, Lawrence J. Eron, Paula D. Sparti, Bernard Bihari, David L. Kaufman, John J. Stern, Daniel Pearce, Winkler G. Weinberg, Anthony LaMarca, Frederick P. Siegal,
Tópico(s)Bacteriophages and microbial interactions
ResumoDisseminated Mycobacterium avium complex infection eventually develops in most patients with the acquired immunodeficiency syndrome (AIDS). This infection results in substantial morbidity and reduces survival by about six months.
Referência(s)